Premier Alternatives

Instylla

Bedford, MA · Founded 2017 · Privately Held (backing)

Developer of a liquid embolic designed for interventional radiology. Instylla is based in Bedford, MA and was founded in 2017. It was valued at $200 million at its later-stage round in Oct 2025, the last priced event on record. It has raised $85.3 million across 5 recorded rounds; the latest was a $21.7 million early-stage round in Jul 2025.

PMV mark · valuation
$199.7M
Oct 2026
Priced at
its later-stage round
Oct 2025
Total raised
$85.3M
Last round
Early Stage VC
Jul 2025

Instylla key facts

as of Oct 2026
  • Developer of a liquid embolic designed for interventional radiology.
  • Instylla is valued at approximately $199.7M as of Oct 2026, set at its later-stage round, Oct 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $85.3M across 5 recorded rounds; the latest was Early Stage VC ($21.7M) in Jul 2025.
  • Notable investors include Ascension Ventures, Sparta Group, AMED Ventures, Angel Physicians Fund, Catalyst Health Ventures — 8 tracked in total.
  • Instylla has filed 5 Form Ds with the SEC since 2017, most recently Nov 2023 ($30.3M sold to 32 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$199.7M

Valued at $199.7M at its later-stage round, Oct 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Instylla with a free account
  • ·Watch Instylla: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Instylla funding rounds

5 rounds
Jul 2025Early Stage VC$21.7MSEC filing▮
Aug 2023Early Stage VC$30.3MSEC filing▮
Aug 2023Early Stage VC$30.3MSEC filing▮
Oct 2020Early Stage VC$25.4MSEC filing▮
May 2017Early Stage VC$8.1MSEC filing▮
Full funding history →

Instylla valuation

Instylla was valued at $200 million at its later-stage round in Oct 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Instylla raised?

Instylla has raised $85.3 million across 5 recorded rounds since 2017. The largest was an $8.1 million early-stage round in May 2017; the most recent was a $21.7 million early-stage round in Jul 2025.

Instylla has filed 5 Form Ds with the SEC since 2017, most recently in Nov 2023 ($30.3 million sold to 32 investors).

Instylla investors

8 investors are on record for Instylla, including Ascension Ventures, Sparta Group, AMED Ventures and Angel Physicians Fund. The early-stage round in Jul 2025 drew 25 investors.

About Instylla

Developer of a liquid embolic designed for interventional radiology. The company's offering is designed for controlled, complete, and persistent embolization and to deliver initial clinical applications in interventional oncology and peripheral hemostasis, enabling healthcare professionals to have access to novel embolization products to improve patient outcomes.

Sector
Healthcare
HQ
Bedford, MA, United States
Founded
2017
Employees
49
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.